# Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

> **NCT00737191** · NA · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Hematopoietic/Lymphoid Cancer
- Pain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** olanzapine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00737191
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No accrual; No patients enrolled
- **Last updated:** 2012-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00737191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00737191, "Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00737191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*